What is INmune Bio Inc (INMB) stock price today?

INmune Bio Inc (INMB) currently trades at $1.33 per share. The stock has a market capitalization of $39.08M and a P/E ratio of —x.

Is INMB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, INmune Bio Inc has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is INmune Bio Inc's revenue and earnings?

INmune Bio Inc has trailing twelve-month (TTM) revenue of $50000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.86.

INMB

INmune Bio Inc

NASDAQ: INMB · HEALTHCARE · BIOTECHNOLOGY

$1.33

-5.00% today

Updated 2026-04-29

Market cap

$39.08M

P/E ratio

—

P/S ratio

781.61x

EPS (TTM)

$-1.86

Dividend yield

—

52W range

$1 – $8

Volume

0.4M

Market cap

$39.08M

P/E ratio

—

P/S ratio

781.61x

EPS (TTM)

$-1.86

Dividend yield

—

52W range

$1 – $8

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$7.00

+426.32%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 257.10% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.66M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$374000.00	$155000.00	$14000.00	$50000.00	$50000.00
Net income	$-28.65M	$-30.01M	$-42.08M	$-45.93M	$-5.26M
EPS	—	—	—	—	$-1.86
Free cash flow	$-22.69M	$-11.98M	$-33.36M	$-23.62M	$-3.66M
Profit margin	-7,659.63%	-19,360.00%	-300,585.71%	-91,866.00%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
INMB	$39.08M	32	5.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

INmune Bio Inc trades at $1.33. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $50000.00.

Frequently asked questions

What is INmune Bio Inc's stock price?

INmune Bio Inc (INMB) trades at $1.33.

Is INmune Bio Inc overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell).

What is the price target of INmune Bio Inc (INMB)?

The analyst target price is $7.00, representing +426.3% upside from the current price of $1.33.

What is INmune Bio Inc's revenue?

TTM revenue is $50000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio781.61x

ROE-165.20%

Beta0.89

50D MA$1.30

200D MA$1.78

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

INMB vs LLY →INMB vs JNJ →INMB vs ABBV →Stock screener →